Search research articles
Contact Us
Filters
Showing results (71-80 of 183) with videos related to
Page
of 19
Sort By:
Cancer Immunology, Immunotherapy : CII
|
January 3, 2025
The correlation between LAG-3 expression and the efficacy of chemoimmunotherapy in advanced biliary tract cancer
Cheng-Yu Tang, Yi-Ting Lin, Yi-Chen Yeh, et al.
Rheumatology (Oxford, England)
|
January 11, 2019
Deltex1 suppresses T cell function and is a biomarker for diagnosis and disease activity of systemic lupus erythematosus
Chuen-Miin Leu, Tzu-Sheng Hsu, Yu-Ping Kuo, et al.
Aging
|
December 8, 2020
Genetic alterations in gastric cancer patients according to sex
Li-Wen Hsu, Kuo-Hung Huang, Ming-Huang Chen, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
November 18, 2020
Comparison of the Long-term Outcome Between Billroth-I and Roux-en-Y Reconstruction Following Distal Gastrectomy for Gastric Cancer
Chia-Hung Wu, Kuo-Hung Huang, Ming-Huang Chen, et al.
Investigational New Drugs
|
June 19, 2015
Phase 1 study of the investigational Aurora A kinase inhibitor alisertib (MLN8237) in East Asian cancer patients: pharmacokinetics and recommended phase 2 dose
Karthik Venkatakrishnan, Tae Min Kim, Chia-Chi Lin, et al.
Biomed Research International
|
August 12, 2014
Cisplatin-based chemotherapy versus cetuximab in concurrent chemoradiotherapy for locally advanced head and neck cancer treatment
Ming-Hung Hu, Ling-Wei Wang, Hsueh-Ju Lu, et al.
Cancer Chemotherapy and Pharmacology
|
April 13, 2011
Triweekly reduced-dose docetaxel combined with cisplatin in recurrent/metastatic head and neck squamous cell carcinoma: a multicenter phase II study
Peter Mu-Hsin Chang, Cheng-Hwai Tzeng, Ming-Huang Chen, et al.
BMC Cancer
|
May 22, 2024
Cost-effectiveness of ivosidenib versus chemotherapy for previously treated IDH1-mutant advanced intrahepatic cholangiocarcinoma in Taiwan
Kuei-An Chen, Wei-Ming Huang, Eric Yi-Ting Chen, et al.
NPJ Precision Oncology
|
August 30, 2025
Circulating miRNAs as potentially predictive biomarkers for chemoimmunotherapy in advanced biliary tract cancer: a post-hoc analysis of the phase II T1219 study
Nai-Jung Chiang, Cheng-Yu Tang, Li-Yuan Bai, et al.
Life (Basel, Switzerland)
|
November 11, 2020
Chromosomal Instability May Not Be a Predictor for Immune Checkpoint Inhibitors from a Comprehensive Bioinformatics Analysis
Chiao-En Wu, Da-Wei Yeh, Yi-Ru Pan, et al.
Page
of 19
Search research articles
Search
Showing results (71-80 of 183) with videos related to
Sort By:
Page
of 19
Cancer Immunology, Immunotherapy : CII
|
January 3, 2025
The correlation between LAG-3 expression and the efficacy of chemoimmunotherapy in advanced biliary tract cancer
Cheng-Yu Tang, Yi-Ting Lin, Yi-Chen Yeh, et al.
Rheumatology (Oxford, England)
|
January 11, 2019
Deltex1 suppresses T cell function and is a biomarker for diagnosis and disease activity of systemic lupus erythematosus
Chuen-Miin Leu, Tzu-Sheng Hsu, Yu-Ping Kuo, et al.
Aging
|
December 8, 2020
Genetic alterations in gastric cancer patients according to sex
Li-Wen Hsu, Kuo-Hung Huang, Ming-Huang Chen, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
November 18, 2020
Comparison of the Long-term Outcome Between Billroth-I and Roux-en-Y Reconstruction Following Distal Gastrectomy for Gastric Cancer
Chia-Hung Wu, Kuo-Hung Huang, Ming-Huang Chen, et al.
Investigational New Drugs
|
June 19, 2015
Phase 1 study of the investigational Aurora A kinase inhibitor alisertib (MLN8237) in East Asian cancer patients: pharmacokinetics and recommended phase 2 dose
Karthik Venkatakrishnan, Tae Min Kim, Chia-Chi Lin, et al.
Biomed Research International
|
August 12, 2014
Cisplatin-based chemotherapy versus cetuximab in concurrent chemoradiotherapy for locally advanced head and neck cancer treatment
Ming-Hung Hu, Ling-Wei Wang, Hsueh-Ju Lu, et al.
Cancer Chemotherapy and Pharmacology
|
April 13, 2011
Triweekly reduced-dose docetaxel combined with cisplatin in recurrent/metastatic head and neck squamous cell carcinoma: a multicenter phase II study
Peter Mu-Hsin Chang, Cheng-Hwai Tzeng, Ming-Huang Chen, et al.
BMC Cancer
|
May 22, 2024
Cost-effectiveness of ivosidenib versus chemotherapy for previously treated IDH1-mutant advanced intrahepatic cholangiocarcinoma in Taiwan
Kuei-An Chen, Wei-Ming Huang, Eric Yi-Ting Chen, et al.
NPJ Precision Oncology
|
August 30, 2025
Circulating miRNAs as potentially predictive biomarkers for chemoimmunotherapy in advanced biliary tract cancer: a post-hoc analysis of the phase II T1219 study
Nai-Jung Chiang, Cheng-Yu Tang, Li-Yuan Bai, et al.
Life (Basel, Switzerland)
|
November 11, 2020
Chromosomal Instability May Not Be a Predictor for Immune Checkpoint Inhibitors from a Comprehensive Bioinformatics Analysis
Chiao-En Wu, Da-Wei Yeh, Yi-Ru Pan, et al.
Page
of 19